F2RL1 and arthritic joint disease: Given the burgeoning problem of arthritis with an ever aging population, the recent and timely publication of the crystal structure of PAR2 (8) presents a landmark step in progressing pharmaceutical research by accelerating development of such agents for future clinical studies.